For example, Tamoxifen resistant breast cancer cells with overexpressed/activated v-akt murine thymoma viral oncogene homolog (AKT) or lack of phosphatase and tensin homologue (PTEN) may benefit from Rapamycin treatment, a highly specific mTOR inhibitor. This evidence concerns the gene PTEN and breast carcinoma.